Taribavirin - CISMeF

Preferred Label : Taribavirin;

NCIt definition : An orally available prodrug of ribavirin, a synthetic nucleoside analog of ribofuranose with activity against a wide range of viruses, especially the hepatitis C virus and influenza virus. Taribavirin is converted into ribavirin, which is incorporated into viral nucleic acid, thereby inhibiting viral RNA synthesis, inducing viral genome mutations, and inhibiting normal viral replication.;

UNII : R3B1994K2E;

InChIKey : NHKZSTHOYNWEEZ-AFCXAGJDSA-N;

CAS number : 119567-79-2;

Chemical formula : C8H13N5O4;

Détails

Origin ID

C76499;

UMLS CUI

C0073221;

Automatic exact mappings (from CISMeF team)
- taribavirin [MeSH concept]
- taribavirin [MeSH Supplementary Concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- taribavirin [MeSH concept]
- taribavirin [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Taribavirin Hydrochloride [NCIt concept]
is_free_acid_or_base_form_of
- Taribavirin Hydrochloride [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients